MFA
BIIB icon

McClarren Financial Advisors’s Biogen BIIB Stock Holding History

McClarren Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2
Closed – – 108
2025
Q1 		$0 Buy
+2
New +$286 ﹤0.01% 282
2024
Q4 		– Sell
-2
Closed – – 217
2024
Q3 		$0 Sell
2
-229
-99% -$47.9K ﹤0.01% 244
2024
Q2 		$0 Buy
231
+229
+11,450% +$49.8K ﹤0.01% 312
2024
Q1 		$1K Hold
2
– – ﹤0.01% 295
2023
Q4 		$1K Hold
2
– – ﹤0.01% 335
2023
Q3 		$0 Hold
2
– – ﹤0.01% 327
2023
Q2 		$0 Hold
2
– – ﹤0.01% 345
2023
Q1 		$0 Hold
2
– – ﹤0.01% 338
2022
Q4 		$0 Buy
+2
New +$565 ﹤0.01% 343

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

McClarren Financial Advisors's BIIB Position: Q2 2025 in Review

McClarren Financial Advisors sold out of Biogen (BIIB) in Q2 2025, closing a stake of 2 shares.

McClarren Financial Advisors first reported a position in BIIB in Q4 2022 and held it in 9 quarters. The position peaked at $1K in Q1 2024. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • McClarren Financial Advisors reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • McClarren Financial Advisors sold 2 Biogen shares in Q2 2025.
  • McClarren Financial Advisors first reported a position in Biogen in Q4 2022 and held it in 9 quarters.
  • McClarren Financial Advisors's Biogen position peaked at $1K in Q1 2024.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on McClarren Financial Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.